CLEW Medical vs Etiometry
Two regulated approaches to critical care risk, and between them they hold the best transparency in this category. CLEW publishes the operating characteristics of its cleared models in a public regulatory document, which means a buyer can read the sensitivity and specificity rather than take them on trust, and it produced the first published measurement of whether clinicians acted on the predictions at all. Etiometry runs four separately cleared physiologic risk indices over a vendor neutral intensive care data layer, publishes SOC 2 Type II with the type named, and describes the implementation shape down to the servers. The technical approaches differ enough that accuracy comparison is misleading: one is machine learning classification, the other is physiologic modelling. Both are explicitly adjunctive, so neither supports an automated response pathway without stepping outside its clearance.
- It publishes the actual operating characteristics of its models in a public regulatory document, which almost nothing else in this category does, so sensitivity and specificity are readable rather than asserted.
- The cleared indications carry an explicit adjunctive constraint stating predictions are for reference only, which bounds what the hospital may build on top of them.
- It produced the first direct measurement of this category's defining failure mode, comparing model output against what clinicians actually did, published in a peer reviewed journal.
- Four separately cleared physiologic risk indices with population specific indications, which is the deepest regulatory footprint in this category, plus a vendor neutral data layer underneath them.
- The best security disclosure in the category by a wide margin, publishing SOC 2 Type II with the type named, against a competitor with no located attestation.
- It publishes the shape of an actual implementation, including hospital installed virtual servers, which is information most vendors reserve for the sales process.
Side by Side
| Axis | C CLEW Medical |
E Etiometry |
|---|---|---|
| AI Centrality | ||
| Autonomy and Oversight Model | ||
| Model and Technology Transparency | ||
| Clinical and Operational Evidence | ||
| AI Safety and PHI Stewardship | ||
| HIPAA and BAA Posture | ||
| Security Certifications and Trust Center | ||
| FDA and Regulatory Status | ||
| AI Governance and Bias Disclosure | ||
| EHR and Interoperability Depth | ||
| Deployment Model and Data Residency | ||
| Commercial Transparency | ||
| Setting and Specialty Coverage |
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Inpatient Deterioration & Risk Monitoring page.
Both products are regulated devices and both are explicitly adjunctive, meaning neither may be used as the sole basis for a therapeutic decision, and a hospital building an automated response pathway on top of either is operating outside the cleared indication. Etiometry's models are physiologic rather than learned classifiers, which is a different technical approach from the machine learning models that dominate this category and should not be compared on accuracy alone. CLEW publishes no security attestation, trust centre or business associate posture, and neither vendor publishes pricing or a unit of pricing such as per monitored bed.